Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world's second largest pharmaceutical market.

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the news to Reuters after it was first reported by China-based financial media outlet Yicai.

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a big, fast-growing market for its blockbuster franchise.

Australia's Prime Minister Anthony Albanese met China's President Xi Jinping in Brazil on Monday, as Beijing seeks to promote Australia as a model for trading with China in a Trump era, even as Canberra draws closer defence ties with Washington.

China's relationship with Australia has achieved a turnaround and the two countries are maintaining a positive momentum of development, Chinese President Xi Jinping told Australian Prime Minister Anthony Albanese on Monday,

"I have always addressed the issue of so-called dual-use goods, because there are different practices, but we must not be naive," Scholz said. He added that he would also tell Xi

China has refuted reports it has been supplying Russia with attack drones as European Union foreign ministers met Monday to discuss the alleged evidence. "China handles the export of military products prudently and responsibly,